Eliminating Critical cGMP Risks Before They Become Inspection Failures.
Regulatory observations, repeat findings and systemic deviations are not isolated events. They signal structural weakness inside quality systems.
We step into complex manufacturing operations to identify, prioritise and remediate the cGMP failures that trigger inspections, warning letters and operational shutdown risk.
Our work stabilises sites under regulatory pressure and builds the governance required for sustained compliance and responsible growth.
We support pharmaceutical manufacturers, CDMOs, cosmetic and private equity investors who require regulatory control, operational stability and protected enterprise value.
Request a confidential discussion with our management team.
Global Aseptic CDMO
Senior Global Director QA
CCS in 6 weeks project
“The whole project was very professionally handled. The experience and knowledge of the Pharmalliance team was outstanding and helped much overcoming misunderstandings and knowledge gaps on our side. Deliverables were provided in time and Pharmalliance kept us on track.”
Sterile Ophthalmic CDMO
QA Remediation Lead
cGMP Remediation Project
“Pharmalliance delivered exactly what we needed – fast, relevant, and high-quality training tailored to our remediation project.
The content was precise and aligned with FDA and EMA expectations for Sterile Manufacturing. Their willingness to adapt the program made a real difference for our team.”
Irish OSD CDMO
Executive Project Lead
Drug Shortage Remediation
“Pharmalliance supplied a team of QA and Engineering specialists who assisted in an operation and quality excellence improvement project.
The result was a marked increase in throughput, which help eliminate a shortage of supply to the market, and a major drop in production downtime.”
Some of our happy clients
Key Services to Increase cGMP Compliance
.jpg)
Address
Glasshouses G2,92 George's Street LowerDún Laoghaire, Dublin, A96 VR66, Ireland
Phone
+353 (0)1 969 2000
